| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |